MGC Diagnostics Corporation
MGCD
MGCD was delisted on the 28th of December, 2017.
12 hedge funds and large institutions have $4.23M invested in MGC Diagnostics Corporation in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 10 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
37% less funds holding
Funds holding: 19 → 12 (-7)
54% less capital invested
Capital invested by funds: $9.21M → $4.23M (-$4.98M)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.21M |
| 2 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$505K |
| 3 |
PCM
Prelude Capital Management
New York
|
+$24.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$23.3K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$12.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$2.59M |
| 2 |
PA
Perceptive Advisors
New York
|
-$2.26M |
| 3 |
BlackRock
New York
|
-$901K |
| 4 |
FM
Fondren Management
Houston,
Texas
|
-$871K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$724K |
MGCD Hedge Fund Activity: Q4 2017 in Review
12 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics Corporation (MGCD) for Q4 2017, worth a combined $4.23M — down 54% from $9.21M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of MGCD and 3 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $2.21M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.59M sold.
- 12 institutional investors held MGC Diagnostics Corporation (MGCD) as of Q4 2017, down from 19 in Q3 2017.
- Funds reported $4.23M of MGC Diagnostics Corporation stock for Q4 2017, down 54% quarter-over-quarter.
- 3 funds opened new MGC Diagnostics Corporation positions in Q4 2017 and 10 closed out, a net change of -7 holders.
- The largest MGC Diagnostics Corporation buyer in Q4 2017 was Kennedy Capital Management, an estimated $2.21M added.
- The largest MGC Diagnostics Corporation seller in Q4 2017 was Renaissance Technologies, an estimated $2.59M sold.
Based on aggregated 13F filings for Q4 2017.